Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Nephrology

Biology & Genetics: How Iminoglycinuria Works

At a Glance

Familial iminoglycinuria is a benign genetic condition caused by mutations in the SLC6A20 or SLC36A2 genes. These changes prevent kidney transporters from recycling the amino acids proline, hydroxyproline, and glycine, causing them to spill into the urine without causing nutritional deficiencies.

To understand iminoglycinuria, it helps to think of your kidneys as a highly efficient recycling center. Every day, your kidneys filter your blood, temporarily dumping out both waste and valuable nutrients. In a healthy kidney, “recycling gates” (transporters) catch the valuable nutrients and pull them back into the bloodstream before they can leave the body as urine.

In familial iminoglycinuria, the instructions for building these recycling gates are slightly different, causing the gates to either work poorly or be missing entirely [1][2].

The Recycling Gates: SIT1 and PAT2

The body uses two primary “gates” in the proximal tubule (the first part of the kidney’s filtering system) to catch three specific nutrients: proline, hydroxyproline, and glycine [2].

  • SIT1 (The specialized gate): This protein (encoded by the SLC6A20 gene) is the primary worker for catching proline and glycine [3][1].
  • PAT2 (The backup gate): This protein (encoded by the SLC36A2 gene) serves as an additional high-affinity system to ensure these amino acids aren’t lost [4].

When the genes for these gates have mutations, the kidney cannot “grab” these three specific amino acids. As a result, they “spill” into the urine [1].

Inheritance: Why Some Only “Spill” Glycine

Iminoglycinuria follows a specific pattern of inheritance that explains why family members might have different test results.

  • Full Iminoglycinuria (Autosomal Recessive): To have the full condition (spilling proline, hydroxyproline, and glycine), a person usually must inherit two changed genes—one from each parent [2].
  • Isolated Hyperglycinuria (Autosomal Dominant): If a person inherits only one changed gene (making them a “carrier”), they often have enough working “gates” to catch all the proline, but they might still lose some glycine into their urine [5][5]. This is why a parent might have a different urine profile than their child.

Because the full condition requires inheriting two mutated genes, you might wonder if your other children or siblings should be tested. Since the condition is benign, routine testing of asymptomatic family members is generally not medically necessary, though you can discuss genetic counseling with your doctor if you have concerns.

The Role of the Chaperone: ACE2

A fascinating discovery in recent years is that the SIT1 transporter cannot get to its job site alone. It requires a “chaperone” protein called ACE2 [6].

(Note: While ACE2 is widely known by the general public as the receptor for the COVID-19 virus, its normal, everyday job as a kidney transporter chaperone is completely unrelated to viral infections.)

Think of ACE2 as a specialized delivery truck. It binds to the SIT1 transporter and carries it to the surface of the kidney cell where it can interact with urine [7][8]. If the ACE2 “truck” isn’t working or cannot “hook up” to the SIT1 transporter, the gate stays stuck inside the cell where it can’t do any recycling [9]. This explains why a problem with the chaperone can cause the same symptoms as a problem with the gate itself.

The Intestinal Connection

The same “gates” (SIT1) and “chaperones” (ACE2) used in the kidneys are also found in the small intestine [3][6]. While some people with iminoglycinuria also have a harder time absorbing these amino acids from food, the body is very smart—it has multiple other ways to get these nutrients, which is why most people with this condition do not have any nutritional deficiencies [10].

Return to the Home Page.

Common questions in this guide

What causes familial iminoglycinuria?
Familial iminoglycinuria is caused by genetic changes that affect how your kidneys recycle specific amino acids. Mutations in genes like SLC6A20 and SLC36A2 prevent the kidney's transport gates from catching proline, hydroxyproline, and glycine, causing them to spill into the urine.
Why do some family members only have glycine in their urine?
People who inherit only one changed gene are considered carriers and may have isolated hyperglycinuria. This means their kidneys have enough working transport gates to catch proline, but they still lose some extra glycine into their urine.
What is the difference between full iminoglycinuria and isolated hyperglycinuria?
Full iminoglycinuria occurs when you inherit two mutated genes, leading to the loss of proline, hydroxyproline, and glycine in the urine. Isolated hyperglycinuria usually happens when you inherit just one mutated gene, causing only glycine to spill into the urine.
Will my children inherit iminoglycinuria?
Because full iminoglycinuria is an autosomal recessive condition, a child usually needs to inherit the mutated gene from both parents to have the full condition. If they inherit the gene from only one parent, they will be a carrier and might only have isolated hyperglycinuria.
Does iminoglycinuria affect how I absorb nutrients from food?
While the same transport gates are used in your small intestine, the body has multiple backup ways to absorb these amino acids. Most people with this condition do not experience any nutritional deficiencies from their diet.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my lab results, do I have 'full' iminoglycinuria or 'isolated' hyperglycinuria?
  2. 2.Does my specific genetic mutation involve the SLC6A20 gene, the SLC36A2 gene, or both?
  3. 3.If I have the 'carrier' state (hyperglycinuria), what is the likelihood that my children will have the full condition?
  4. 4.Is there any concern about my body's ability to absorb these same amino acids in my digestive tract?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Structure and function of the SIT1 proline transporter in complex with the COVID-19 receptor ACE2.

    Li HZ, Pike ACW, Lotsaris I, et al.

    Nature communications 2024; (15(1)):5503 doi:10.1038/s41467-024-48921-x.

    PMID: 38951531
  2. 2

    The SLC6A15-SLC6A20 Neutral Amino Acid Transporter Subfamily: Functions, Diseases, and Their Therapeutic Relevance.

    Kukułowicz J, Pietrzak-Lichwa K, Klimończyk K, et al.

    Pharmacological reviews 2023; (76(1)):142-193 doi:10.1124/pharmrev.123.000886.

    PMID: 37940347
  3. 3

    Intestinal IMINO transporter SIT1 is not expressed in human newborns.

    Meier C, Camargo SM, Hunziker S, et al.

    American journal of physiology. Gastrointestinal and liver physiology 2018; (315(5)):G887-G895 doi:10.1152/ajpgi.00318.2017.

    PMID: 30160974
  4. 4

    The Role of Proton-Coupled Amino Acid Transporter 2 (SLC36A2) in Cold-Induced Thermogenesis of Mice.

    Shu H, Zhang J, Cheng D, et al.

    Nutrients 2023; (15(16)) doi:10.3390/nu15163552.

    PMID: 37630739
  5. 5

    Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report.

    Jv M, Zheng J, Yang A, et al.

    Open medicine (Warsaw, Poland) 2023; (18(1)):20230648 doi:10.1515/med-2023-0648.

    PMID: 36820062
  6. 6

    ACE2 and gut amino acid transport.

    Camargo SMR, Vuille-Dit-Bille RN, Meier CF, Verrey F

    Clinical science (London, England : 1979) 2020; (134(21)):2823-2833 doi:10.1042/CS20200477.

    PMID: 33140827
  7. 7

    Expression of SARS-CoV-2 entry factors, electrolyte, and mineral transporters in different mouse intestinal epithelial cell types.

    Pearce SC, Suntornsaratoon P, Kishida K, et al.

    Physiological reports 2021; (9(21)):e15061 doi:10.14814/phy2.15061.

    PMID: 34755492
  8. 8

    Cryo-EM structure of ACE2-SIT1 in complex with tiagabine.

    Bröer A, Hu Z, Kukułowicz J, et al.

    The Journal of biological chemistry 2024; (300(9)):107687 doi:10.1016/j.jbc.2024.107687.

    PMID: 39159813
  9. 9

    Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?

    Hu Y, Liu L, Lu X

    Frontiers in endocrinology 2021; (12()):725967 doi:10.3389/fendo.2021.725967.

    PMID: 34745001
  10. 10

    Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors.

    Vuille-dit-Bille RN, Camargo SM, Emmenegger L, et al.

    Amino acids 2015; (47(4)):693-705 doi:10.1007/s00726-014-1889-6.

    PMID: 25534429

This page explains the biology and genetics of iminoglycinuria for educational purposes only. Always consult your nephrologist or genetic counselor for advice specific to your family's health and genetic testing.

Get notified when new evidence is published on Iminoglycinuria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.